Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation.
about
Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.Amyloidosis and POEMS syndrome.Protective effect of quercetin on melphalan-induced oxidative stress and impaired renal and hepatic functions in rat.Kidney disease associated with plasma cell dyscrasiasCurrent status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.Kidney disease and multiple myeloma.The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation.Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis.Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantation.Late onset renal failure and nephrotic syndrome after autologous stem cell transplant for Al amyloidosis.
P2860
Q30275870-2AB942DC-248D-432E-89C7-0B4D813648CEQ33388255-5E4EC686-4F8E-46DE-BC08-25D0466C1298Q33867198-421D6DBD-6175-4A54-B265-916C9F238F0DQ34773920-2230535F-7222-49DE-8DD3-DF8FCC100CF8Q37750106-9D0D9B4D-C9D4-44CA-8B8D-4F168D2BB679Q37904673-5E489221-E23A-4B1B-9B93-2626DFA15BE1Q38122674-6C8E44ED-0A2C-4628-AB8E-A611B81CA142Q40252288-FF8675D6-0A82-4386-9085-63B4BF8AC993Q44468671-189A220F-3302-4B65-8E54-55C9A21C3F9EQ45896840-B224233A-982D-4EB3-8395-4DF571954E16Q48382207-7142DB10-91F6-400E-B6EB-775FF8B4B10BQ50671900-1306A044-4FA8-497E-86DF-8B06E2440803Q53177296-C4C12C66-7366-47BB-AFEF-51811C95BBC0
P2860
Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Acute renal insufficiency afte ...... ing stem cell transplantation.
@en
Acute renal insufficiency afte ...... ing stem cell transplantation.
@nl
type
label
Acute renal insufficiency afte ...... ing stem cell transplantation.
@en
Acute renal insufficiency afte ...... ing stem cell transplantation.
@nl
prefLabel
Acute renal insufficiency afte ...... ing stem cell transplantation.
@en
Acute renal insufficiency afte ...... ing stem cell transplantation.
@nl
P2093
P50
P1476
Acute renal insufficiency afte ...... ing stem cell transplantation.
@en
P2093
Erik J Bergstralh
Jeff M Slezak
Robert C Wolf
P304
P356
10.1053/J.AJKD.2004.09.015
P577
2005-01-01T00:00:00Z